radioligand therapy for prostate cancerClinical Trials

Clinical Trials

ClinicalTrials.gov studies linked to the NIH projects in this sample. Click a phase chip below to filter.

Distribution — click to filter

Clinical Trials(500)

173 active · 244 completed · 74 stopped

Study	Phase	Status	Sponsor	Enroll
64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer NCT07608627	Phase 1	Not yet recruiting	City of Hope Medical Center	15
CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma NCT07659678	Phase 2	Not yet recruiting	Washington University School of Medicine	90
Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer NCT07682649	Phase 1	Not yet recruiting	University of Michigan Rogel Cancer Center	20
A Safety Study of 212Pb-Pentixather Radioligand Therapy NCT05557708	Early Phase 1	Not yet recruiting	Yusuf Menda	20
Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer NCT07197671	Phase 1	Recruiting	University of Wisconsin, Madison	60
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial NCT07276438	N/A	Recruiting	Jonsson Comprehensive Cancer Center	186
Mental Health App for Cancer Survivors Study NCT06472726	N/A	Terminated	University of Wisconsin, Madison	1
PET [89Zr]DFO-starPEG in Solid Tumors NCT06894745	Phase 1	Recruiting	Robert Flavell, MD, PhD	13
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization NCT06389097	Observational	Recruiting	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	80
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy NCT07096999	Observational	Recruiting	University of Michigan Rogel Cancer Center	60
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer NCT06236139	Phase 1	Recruiting	Fred Hutchinson Cancer Center	48
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer NCT06391034	Phase 2	Recruiting	Robert Bok, MD, PhD	161
Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma NCT06308913	Early Phase 1	Active, not recruiting	University of Wisconsin, Madison	12
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer NCT06145633	Phase 2	Recruiting	Fred Hutchinson Cancer Center	15
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) NCT06150417	Phase 2	Recruiting	Case Comprehensive Cancer Center	200
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study NCT06039371	Phase 2	Recruiting	University of Washington	69
A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors NCT06148636	Early Phase 1	Active, not recruiting	David Bushnell	24
Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors NCT05599048	Phase 1	Recruiting	Robert Bok, MD, PhD	65
A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent NCT05111509	Early Phase 1	Active, not recruiting	Yusuf Menda	20
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer NCT04989946	Phase 1	Active, not recruiting	University of Wisconsin, Madison	60
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer NCT04943536	Phase 1	Active, not recruiting	Alessa Therapeutics Inc.	20
Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study NCT04870515	N/A	Completed	Fred Hutchinson Cancer Center	20
Mechanisms of Resistance to PSMA Radioligand Therapy NCT05435495	Observational	Recruiting	University of California, San Francisco	125
Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer NCT04892303	Phase 1	Recruiting	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	48
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer NCT03649841	Phase 2	Terminated	University of Washington	10
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study NCT04472338	Observational	Recruiting	University of Washington	450
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer NCT04151940	N/A	Recruiting	University of Washington	80
Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study NCT04254133	Observational	Enrolling by invitation	Fred Hutchinson Cancer Center	1,360
Genetic Testing for Men With Metastatic Prostate Cancer NCT03503097	Observational	Terminated	University of Washington	799
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer NCT02526368	Early Phase 1	Recruiting	Ivan de Kouchkovsky, MD	80
Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer NCT02565901	Phase 1	Terminated	University of Washington	28
Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway NCT02598895	Phase 2	Completed	University of Washington	14
Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer NCT02532114	Phase 1	Completed	University of Washington	5
CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer NCT01881867	Phase 2	Completed	Fred Hutchinson Cancer Center	54
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer NCT01576172	Phase 2	Completed	National Cancer Institute (NCI)	159
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer NCT01050504	Observational	Recruiting	University of Washington	1,500
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer NCT00002889	Phase 2	Completed	Alliance for Clinical Trials in Oncology	180
PET Scan in Treating Patients With Metastatic Prostate Cancer NCT00002981	N/A	Completed	Memorial Sloan Kettering Cancer Center	173
Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer NCT00003045	N/A	Completed	Dana-Farber Cancer Institute	38
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer NCT00006359	Phase 2	Completed	Alliance for Clinical Trials in Oncology	63
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer NCT00016913	Phase 2	Completed	Alliance for Clinical Trials in Oncology	34
CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy NCT00020891	Phase 2	Completed	Memorial Sloan Kettering Cancer Center	25
Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer NCT00062309	Phase 3	Completed	Fox Chase Cancer Center	307
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer NCT00067015	Phase 3	Completed	Memorial Sloan Kettering Cancer Center	3
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases NCT00081159	Phase 2	Completed	M.D. Anderson Cancer Center	80
Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes NCT00214136	Phase 2	Completed	University of Wisconsin, Madison	30
Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer NCT00217516	Phase 1	Completed	Roswell Park Cancer Institute	18
Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer NCT00243048	Phase 2	Completed	Barbara Ann Karmanos Cancer Institute	70
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer NCT00258466	Phase 3	Withdrawn	Barbara Ann Karmanos Cancer Institute	—
Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer NCT00482807	Phase 1	Completed	University of Nebraska	9
Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) NCT00495040	Phase 2	Completed	M.D. Anderson Cancer Center	38
Observation or Radical Treatment in Patients With Prostate Cancer NCT00499174	N/A	Terminated	NCIC Clinical Trials Group	180
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery NCT00530010	Observational	Completed	Northwestern University	500
Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery NCT00532740	Observational	Completed	Northwestern University	2,000
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer NCT00544830	Phase 2	Active, not recruiting	City of Hope Medical Center	29
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer NCT00589472	Phase 2	Completed	National Cancer Institute (NCI)	19
Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer NCT00619515	N/A	Terminated	Case Comprehensive Cancer Center	73
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer NCT00653757	Phase 1	Completed	Mayo Clinic	100
Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy NCT00684905	Phase 2	Completed	Mayo Clinic	50
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer NCT00714753	Phase 2	Completed	Mayo Clinic	5
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy NCT00738452	Phase 1	Completed	City of Hope Medical Center	10
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy NCT00788307	Phase 1	Terminated	Mayo Clinic	8
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer NCT00928174	Phase 1	Completed	Queen's Medical Center	27
Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer NCT00928252	Phase 1	Completed	Queen's Medical Center	25
Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer NCT01023061	Phase 2	Completed	University of Washington	24
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer NCT01120236	Phase 2	Completed	National Cancer Institute (NCI)	211
In Vivo Dosimetry During Prostate Cancer Radiotherapy NCT01307852	Phase 1	Completed	M.D. Anderson Cancer Center	7
S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma NCT01359592	Phase 2	Completed	SWOG Cancer Research Network	159
MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer NCT01411319	N/A	Completed	University of Miami	25
MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer NCT01792024	N/A	Completed	University of Chicago	27
Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T NCT01833208	N/A	Active, not recruiting	Roswell Park Cancer Institute	15
FOcal RECurrent Assessment and Salvage Treatment NCT01883128	Phase 2	Unknown status	University College London Hospitals	177
Hypofractionated Proton Beam Therapy for Localized Prostate Cancer NCT01950351	Phase 1	Recruiting	M.D. Anderson Cancer Center	241
LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer NCT02058706	Phase 2	Completed	Barbara Ann Karmanos Cancer Institute	71
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer NCT02163317	N/A	Recruiting	Case Comprehensive Cancer Center	12
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer NCT02206334	Phase 1	Completed	NRG Oncology	42
MRI Based Active Selection for Treatment Trial NCT02242773	N/A	Completed	University of Miami	208
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer NCT02296229	N/A	Recruiting	Jonsson Comprehensive Cancer Center	220
Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer NCT02353819	Phase 1	Active, not recruiting	University of Texas Southwestern Medical Center	60
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer NCT02420977	Early Phase 1	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	23
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer NCT02429804	Phase 1	Terminated	Stanford University	4
68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer NCT02440308	Phase 2	Completed	Stanford University	10
Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer NCT02458716	Phase 1	Completed	Rutgers, The State University of New Jersey	26
PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer NCT02472275	Phase 1	Completed	Barbara Ann Karmanos Cancer Institute	8
68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer NCT02488070	Phase 1	Completed	Stanford University	10
Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy NCT02597894	N/A	Withdrawn	Jonsson Comprehensive Cancer Center	—
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer NCT02624518	Phase 2	Recruiting	Andrei Iagaru	122
Targeted Fusion Biopsy of the Prostate NCT02744534	Phase 2	Completed	Emory University	21
68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients NCT02747290	Early Phase 1	Unknown status	Peking Union Medical College Hospital	30
Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery NCT02830165	N/A	Completed	Jonsson Comprehensive Cancer Center	11
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy NCT02940262	Phase 3	Recruiting	Jonsson Comprehensive Cancer Center	1,138
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery NCT02949284	Phase 2	Active, not recruiting	Rutgers, The State University of New Jersey	90
Dosimetry Guided PRRT With 90Y-DOTATOC NCT03013387	Phase 2	Withdrawn	Sue O'Dorisio	—
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery NCT03070886	Phase 2	Completed	NRG Oncology	612
68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients NCT03164837	Phase 1	Unknown status	Peking Union Medical College Hospital	30
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies NCT03217747	Phase 1	Recruiting	M.D. Anderson Cancer Center	173
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) NCT03273712	Phase 2	Completed	University of Iowa	39
177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors NCT03308682	Phase 1	Unknown status	Peking Union Medical College Hospital	30
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis NCT03317392	Phase 1	Active, not recruiting	National Cancer Institute (NCI)	145
Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer NCT03344211	Phase 2	Active, not recruiting	University of Southern California	30
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer NCT03358563	Early Phase 1	Active, not recruiting	University of Wisconsin, Madison	30
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer NCT03367702	Phase 3	Active, not recruiting	NRG Oncology	692
68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery NCT03368547	N/A	Recruiting	Jonsson Comprehensive Cancer Center	400
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial NCT03371719	Phase 2	Active, not recruiting	NRG Oncology	324
177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer NCT03403595	Phase 1	Unknown status	Peking Union Medical College Hospital	30
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer NCT03456843	Phase 2	Active, not recruiting	Yale University	190
Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery NCT03515577	Phase 2	Completed	Jonsson Comprehensive Cancer Center	50
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery NCT03541850	Phase 2	Recruiting	Jonsson Comprehensive Cancer Center	92
Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy NCT03582774	Phase 3	Active, not recruiting	Jonsson Comprehensive Cancer Center	193
Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy NCT03596710	N/A	Withdrawn	Jonsson Comprehensive Cancer Center	—
177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer NCT03805594	Phase 1	Completed	University of California, San Francisco	43
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT NCT03861676	Early Phase 1	Recruiting	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	20
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer NCT03902951	Phase 2	Not yet recruiting	Jonsson Comprehensive Cancer Center	28
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer NCT04050215	Phase 2	Recruiting	Jonsson Comprehensive Cancer Center	937
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study NCT04071223	Phase 2	Active, not recruiting	National Cancer Institute (NCI)	134
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy NCT04071236	Phase 1	Suspended	National Cancer Institute (NCI)	90
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones NCT04090398	Phase 2	Active, not recruiting	National Cancer Institute (NCI)	70
CLR 131 Combined With Radiation for Head and Neck Cancer NCT04105543	Phase 1	Completed	University of Wisconsin, Madison	12
Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers NCT04106843	Phase 2	Not yet recruiting	M.D. Anderson Cancer Center	—
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial NCT04134260	Phase 3	Active, not recruiting	NRG Oncology	586
Radiation Therapy (Hypofractionated Proton Beam Therapy or IMRT) for the Treatment of Recurrent, Oligometastatic Prostate Cancer Following Primary Localized Treatment NCT04190446	Phase 2	Suspended	Mayo Clinic	84
68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer NCT04216134	Phase 1	Completed	City of Hope Medical Center	19
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer NCT04253483	Phase 2	Active, not recruiting	Rutgers, The State University of New Jersey	14
HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer NCT04264208	Phase 2	Terminated	Andrei Iagaru	4
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer NCT04402151	Phase 2	Recruiting	Weill Medical College of Cornell University	50
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging NCT04423211	Phase 3	Recruiting	ECOG-ACRIN Cancer Research Group	804
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer NCT04489719	Observational	Recruiting	University of Washington	48
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial NCT04513717	Phase 3	Active, not recruiting	NRG Oncology	2,753
Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones NCT04616547	Phase 2	Terminated	National Cancer Institute (NCI)	1
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer NCT04725903	N/A	Recruiting	Emory University	30
68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer NCT04762888	Phase 2	Recruiting	Mayo Clinic	52
PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer NCT04910425	Phase 2	Withdrawn	Northwestern University	—
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study NCT05053152	Phase 2	Active, not recruiting	NRG Oncology	194
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer NCT05176223	Phase 2	Recruiting	Mayo Clinic	29
RElugolix VErsus LeUprolide Cardiac Trial NCT05320406	Phase 2	Active, not recruiting	Emory University	94
RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer NCT05470699	N/A	Active, not recruiting	City of Hope Medical Center	34
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer NCT05547386	Phase 3	Enrolling by invitation	Mayo Clinic	163
Dual-Tracer Theranostic PET NCT05680675	N/A	Completed	University of Utah	50
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells NCT05691465	Phase 2	Recruiting	National Cancer Institute (NCI)	30
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy NCT05710380	N/A	Recruiting	University of Chicago	180
Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors NCT05724108	Phase 2	Active, not recruiting	National Cancer Institute (NCI)	94
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer NCT05805371	Phase 1	Recruiting	City of Hope Medical Center	21
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma NCT05830058	Phase 2	Recruiting	City of Hope Medical Center	32
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance NCT05852041	Early Phase 1	Recruiting	Northwestern University	40
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma NCT06014827	Phase 2	Suspended	City of Hope Medical Center	32
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc NCT06084338	Phase 2	Recruiting	VA Office of Research and Development	60
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer NCT06105918	Phase 1	Active, not recruiting	Emory University	6
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer NCT06129851	Phase 2	Not yet recruiting	University of Kansas Medical Center	90
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial NCT06244004	Phase 2	Recruiting	Northwestern University	125
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial NCT06378866	Phase 2	Recruiting	Mayo Clinic	532
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial NCT06499870	Phase 2	Recruiting	Northwestern University	50
Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases NCT06549478	Phase 1	Suspended	City of Hope Medical Center	24
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer NCT06580015	N/A	Active, not recruiting	City of Hope Medical Center	20
An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial NCT06813898	Early Phase 1	Recruiting	Northwestern University	27
Comprehensive Assessment of Cancer Theranostic Response NCT06815354	N/A	Recruiting	AIQ Solutions	32
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique NCT06865768	Phase 2	Recruiting	Emory University	90
Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors. NCT07150546	Phase 1	Recruiting	Emory University	15
Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R) NCT07210086	Phase 2	Recruiting	City of Hope Medical Center	50
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer NCT07219147	Phase 1	Recruiting	City of Hope Medical Center	30
Low-Count Quantitative SPECT for Men Treated With Radium-223 NCT07221825	N/A	Recruiting	Washington University School of Medicine	38
Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Prostate Cancer NCT07769372	N/A	Not yet recruiting	City of Hope Medical Center	20
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer NCT05779943	Phase 2	Active, not recruiting	Emory University	20
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery NCT00438464	Phase 2	Completed	National Cancer Institute (NCI)	204
An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer NCT04318028	N/A	Completed	University of Southern California	20
Expanding Genetic Access for Prostate Cancer Survivors NCT07618520	N/A	Not yet recruiting	Georgetown University	500
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor NCT00161187	Phase 1	Completed	University of Medicine and Dentistry of New Jersey	37
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI NCT06315595	Observational	Recruiting	Mayo Clinic	1,000
End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer NCT01389830	Observational	Unknown status	M.D. Anderson Cancer Center	230
Robot-Assisted MRI-Guided Prostate Biopsy NCT02080052	N/A	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	5
Cabozantinib in Men With Castration-Resistant Prostate Cancer NCT01703065	Phase 2	Terminated	University of Washington	9
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction NCT01638533	Phase 1	Completed	National Cancer Institute (NCI)	37
Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery NCT02446366	N/A	Unknown status	University of Southern California	24
Clinical Trial of Approaches to Prostate Cancer Surgery NCT05155501	N/A	Recruiting	Weill Medical College of Cornell University	600
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients NCT03987217	Early Phase 1	Completed	University of Utah	73
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) NCT05056077	N/A	Active, not recruiting	University of California, San Francisco	1,000
Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy NCT03412396	Phase 2	Active, not recruiting	M.D. Anderson Cancer Center	45
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074	Phase 1	Completed	National Cancer Institute (NCI)	15
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer NCT05828082	Phase 2	Active, not recruiting	National Cancer Institute (NCI)	20
Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer NCT02151760	Phase 1	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	37
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer NCT02176902	N/A	Active, not recruiting	Jonsson Comprehensive Cancer Center	107
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) NCT00031681	Phase 1	Completed	National Cancer Institute (NCI)	41
Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer NCT01163084	Phase 1	Terminated	National Cancer Institute (NCI)	10
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring NCT04037254	Phase 1	Completed	NRG Oncology	22
Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients NCT03740035	Observational	Terminated	Wake Forest University Health Sciences	4
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients NCT00253383	N/A	Completed	Dartmouth-Hitchcock Medical Center	329
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance NCT03933670	Phase 2	Recruiting	University of California, San Francisco	60
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors NCT03284346	N/A	Terminated	University of Southern California	23
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers NCT00984919	Observational	Completed	Barbara Ann Karmanos Cancer Institute	10
Clinical Trial of Green Tea Catechins in Men on Active Surveillance NCT04300855	Phase 2	Active, not recruiting	H. Lee Moffitt Cancer Center and Research Institute	115
Addressing Health Literacy With a Tailored Survivorship Care Plan NCT06674863	N/A	Recruiting	Emory University	150
Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide NCT02228265	Observational	Active, not recruiting	OHSU Knight Cancer Institute	41
Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer NCT00336934	N/A	Completed	Roll International Corporation	183
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel NCT01253642	Phase 2	Terminated	OHSU Knight Cancer Institute	11
Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy NCT03135782	N/A	Recruiting	OHSU Knight Cancer Institute	2
Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer NCT01562223	N/A	Unknown status	American College of Radiology Imaging Network	30
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer NCT00450229	Phase 1	Completed	National Cancer Institute (NCI)	45
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors NCT00335491	N/A	Completed	University of Utah	49
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer NCT06173362	Phase 2	Recruiting	Mamta Parikh	75
Selenium in Preventing Prostate Cancer NCT00978718	Phase 3	Completed	University of Arizona	700
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial NCT06650579	Phase 3	Recruiting	Emory University	72
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer NCT03709550	Phase 1	Withdrawn	Roswell Park Cancer Institute	—
Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer NCT00080808	Phase 2	Completed	M.D. Anderson Cancer Center	111
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer NCT00253708	N/A	Completed	Beth Israel Deaconess Medical Center	39
Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer NCT06178354	N/A	Recruiting	Marc Dall'Era, MD	100
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer NCT00499733	Early Phase 1	Terminated	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	19
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy NCT00892736	Phase 1	Completed	National Cancer Institute (NCI)	98
Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy NCT00888654	Phase 2	Completed	Barbara Ann Karmanos Cancer Institute	41
Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Participants With Recurrent Prostate Cancer NCT01786265	Phase 2	Active, not recruiting	M.D. Anderson Cancer Center	310
Intensive Diet and Exercise or Standard of Care in Improving Physical Function and Quality of Life in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy NCT02050906	N/A	Completed	Ohio State University Comprehensive Cancer Center	32
The Effects of Lycopene on High Risk Prostatic Tissue NCT01443026	Phase 2	Completed	University of Illinois at Chicago	66
Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis NCT00798187	Observational	Terminated	M.D. Anderson Cancer Center	240
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants NCT00898274	Observational	Completed	Case Comprehensive Cancer Center	40
Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer NCT02237612	N/A	Completed	University of Southern California	9
Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education NCT02871752	N/A	Completed	Northwestern University	225
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy NCT04288336	Early Phase 1	Withdrawn	Mayo Clinic	—
Vitamin D for Prostate Endocrine Therapy NCT05838716	Phase 3	Recruiting	University of Rochester	240
Soccer Intervention in Prostate Cancer Survivors NCT04144127	N/A	Completed	Emory University	3
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) NCT02465060	Phase 2	Active, not recruiting	National Cancer Institute (NCI)	6,452
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction NCT00030498	Phase 1	Completed	National Cancer Institute (NCI)	75
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe NCT05965180	Observational	Recruiting	University of Michigan Rogel Cancer Center	50
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients NCT01434342	Early Phase 1	Completed	Wake Forest University Health Sciences	146
Tailored Web-Based Intervention for Cancer Patients and Family Caregivers NCT01415089	N/A	Completed	University of Michigan	63
PRISM: Patient Experiences With PET Imaging in Prostate Cancer NCT06523777	Observational	Active, not recruiting	Yale University	350
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors NCT00003038	Phase 1	Completed	Mayo Clinic	—
Massage for Prostate Cancer-Related Fatigue (mPROSTATE) NCT05067777	Phase 2	Terminated	University of Utah	28
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer NCT02522715	Phase 1	Recruiting	OHSU Knight Cancer Institute	37
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance NCT02095145	Phase 2	Completed	National Cancer Institute (NCI)	38
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer NCT00087035	Phase 2	Completed	Jonsson Comprehensive Cancer Center	1
Early Changes In Multiparametric MRI In Prostate Cancer NCT01959542	N/A	Completed	Dana-Farber Cancer Institute	15
Massage Therapy for Cancer-Related Fatigue NCT00039793	Phase 2	Completed	National Center for Complementary and Integrative Health (NCCIH)	45
Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer NCT01928485	Phase 2	Terminated	Sanjay Gupta PhD	6
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer NCT06398639	N/A	Recruiting	Adam S. Kibel, MD	1,500
Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors NCT02150148	N/A	Completed	University of Alabama at Birmingham	46
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer NCT03697148	N/A	Active, not recruiting	ECOG-ACRIN Cancer Research Group	852
AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients NCT05375539	Phase 1	Completed	Milton S. Hershey Medical Center	12
KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice NCT04763824	N/A	Completed	University of Kansas Medical Center	15
Hypofractionated Radiation Therapy in Treating Participants With Prostate Cancer High-Risk Features Following Radical Prostatectomy NCT03570827	Phase 2	Active, not recruiting	Mayo Clinic	52
Michigan Genetic Hereditary Testing (MiGHT) NCT05162846	N/A	Completed	University of Michigan Rogel Cancer Center	831
Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer NCT02339168	Phase 1	Completed	University of California, Davis	25
Testosterone Therapy in Castration Resistant Prostate Cancer NCT03734653	Early Phase 1	Active, not recruiting	University of Colorado, Denver	30
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors NCT07001241	Phase 2	Recruiting	University of Colorado, Denver	134
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer NCT00170157	Phase 2	Completed	Mayo Clinic	112
Soy Protein/Effexor Hormone Therapy for Prostate Cancer NCT00354432	Phase 3	Terminated	Wake Forest University Health Sciences	120
Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer NCT00060086	N/A	Active, not recruiting	Jonsson Comprehensive Cancer Center	47
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners NCT03112668	N/A	Completed	Rutgers, The State University of New Jersey	14
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer NCT03963739	Observational	Completed	Wake Forest University Health Sciences	255
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial NCT06016725	N/A	Completed	Ohio State University Comprehensive Cancer Center	75
Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer NCT01828476	Phase 2	Terminated	Rutgers, The State University of New Jersey	13
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy NCT00052845	Phase 2	Completed	Alliance for Clinical Trials in Oncology	80
Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer NCT03122743	Observational	Completed	Wake Forest University Health Sciences	61
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer NCT00005096	Phase 2	Completed	Dana-Farber Cancer Institute	19
FACBC PET/CT for Recurrent Prostate Cancer NCT00562315	Phase 2	Completed	David M. Schuster, MD	128
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy NCT00002924	Observational	Completed	Alliance for Clinical Trials in Oncology	184
PS-341 Followed by Removal of Prostate for Those With Prostate Cancer NCT00425503	Phase 2	Completed	Baylor College of Medicine	40
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects NCT03248570	Phase 2	Completed	University of California, San Francisco	26
Proteases in Patients With Prostate Cancer That Has Spread to the Bone NCT00899665	Observational	Completed	Barbara Ann Karmanos Cancer Institute	31
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. NCT00258401	N/A	Completed	Case Comprehensive Cancer Center	11
Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men NCT02969577	N/A	Completed	University of Kansas Medical Center	38
Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer NCT02516670	Phase 2	Terminated	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	50
Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells NCT02425800	Observational	Completed	Wake Forest University Health Sciences	43
Linsitinib in Treating Patients With Asymptomatic or Mildly Symptomatic Metastatic Prostate Cancer NCT01533246	Phase 2	Completed	National Cancer Institute (NCI)	17
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate NCT03582475	Phase 1	Recruiting	Jonsson Comprehensive Cancer Center	15
Prostate Cancer Prospective Cohort NCT00937586	Observational	Active, not recruiting	Washington University School of Medicine	1,937
Streamlined Genetic Testing in Prostate Cancer NCT04359758	N/A	Completed	Georgetown University	112
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases NCT00874211	Observational	Completed	SWOG Cancer Research Network	3,571
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer NCT01480154	Phase 1	Active, not recruiting	National Cancer Institute (NCI)	62
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer NCT03665922	N/A	Completed	University of Pittsburgh	39
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone NCT00392938	Observational	Completed	University of Washington	11
Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy NCT00005857	Phase 2	Completed	City of Hope Medical Center	—
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820	Phase 1	Completed	Roswell Park Cancer Institute	18
Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer NCT02169063	N/A	Withdrawn	University of Washington	—
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study NCT04081779	N/A	Completed	Fred Hutchinson Cancer Center	261
SOR-C13 in Treating Patients With Advanced Refractory Solid Tumors NCT03784677	Phase 1	Recruiting	M.D. Anderson Cancer Center	11
Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy NCT00937768	Phase 2	Terminated	Mayo Clinic	16
Carbohydrate Restriction and Prostate Cancer Growth NCT01763944	N/A	Completed	Duke University	83
Characterize Tumor Hypoxia by Magnetic Resonance Imaging NCT03987568	N/A	Withdrawn	Wake Forest University Health Sciences	—
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer NCT00942331	Phase 3	Completed	National Cancer Institute (NCI)	506
Perspectives About Online Information NCT07631858	N/A	Not yet recruiting	NYU Langone Health	3,200
Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery NCT03152786	Phase 2	Terminated	Wake Forest University Health Sciences	46
KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer NCT02337465	N/A	Recruiting	Case Comprehensive Cancer Center	30
Tivantinib in Treating Patients With Metastatic Prostate Cancer NCT01519414	Phase 2	Completed	National Cancer Institute (NCI)	78
Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate NCT00084864	Phase 2	Terminated	Roswell Park Cancer Institute	25
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer NCT00176579	Observational	Completed	University of Medicine and Dentistry of New Jersey	27
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners NCT04189770	Observational	Active, not recruiting	M.D. Anderson Cancer Center	200
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy NCT04927559	Observational	Terminated	University of Southern California	35
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer NCT04981834	N/A	Suspended	University of Southern California	196
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer NCT05733351	Phase 1	Terminated	Emory University	4
Resistance Training and Protein Supplementation for Prostate Cancer Survivors NCT01909440	N/A	Completed	University of Southern California	43
Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA NCT02989623	N/A	Completed	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	25
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer NCT02012296	Phase 1	Completed	University of Chicago	88
Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer NCT00258284	Phase 2	Completed	Barbara Ann Karmanos Cancer Institute	30
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer NCT00036790	Phase 1	Completed	University of Wisconsin, Madison	—
Robotic Seed Implantation for Prostate Cancer Brachytherapy NCT01341288	Phase 1	Terminated	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	2
Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis NCT00918645	N/A	Terminated	University of California, Davis	13
Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases NCT00936975	Phase 2	Completed	National Cancer Institute (NCI)	18
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer NCT00016107	Phase 2	Completed	National Cancer Institute (NCI)	72
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer NCT01026623	Phase 1	Completed	National Cancer Institute (NCI)	16
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer NCT03563352	Observational	Withdrawn	University of Southern California	—
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer NCT04337580	Phase 2	Recruiting	Wake Forest University Health Sciences	50
Active Surveillance in Prostate Cancer NCT00490763	Observational	Completed	M.D. Anderson Cancer Center	1,139
CHESS: Human and Computer Mentors for Prostate Cancer Patients NCT00516256	N/A	Completed	M.D. Anderson Cancer Center	209
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer NCT00023634	Phase 1	Terminated	SWOG Cancer Research Network	14
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer NCT00905086	Observational	Completed	Case Comprehensive Cancer Center	80
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery NCT03218826	Phase 1	Completed	National Cancer Institute (NCI)	23
64Cu-GRIP B in Patients With Advanced Malignancies NCT05888532	Phase 1	Recruiting	Rahul Aggarwal	91
Collection of Patient-Reported Symptoms and Performance Status Via the Internet NCT00417040	N/A	Completed	Alliance for Clinical Trials in Oncology	325
Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer NCT01093183	Phase 1	Terminated	University of Nebraska	25
Taste Acceptability of Tomato-Soy-Arugula Seed Beverages in Men With Prostate Cancer NCT02927899	N/A	Completed	Ohio State University Comprehensive Cancer Center	27
Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) NCT07102212	N/A	Suspended	Ohio State University Comprehensive Cancer Center	120
Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease NCT03081884	Phase 2	Completed	Emory University	61
Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate NCT00991315	Observational	Terminated	Rutgers, The State University of New Jersey	126
Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer NCT00736164	Phase 2	Withdrawn	Roswell Park Cancer Institute	—
Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery NCT00458549	N/A	Terminated	Dana-Farber Cancer Institute	232
Internet-Based Exercise and Diet Support in Prostate Cancer Survivors NCT03406013	N/A	Active, not recruiting	OHSU Knight Cancer Institute	206
Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy NCT03725761	Phase 2	Active, not recruiting	University of Wisconsin, Madison	31
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy NCT00005820	Phase 2	Completed	Alliance for Clinical Trials in Oncology	35
Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate NCT00078923	Phase 2	Completed	Barbara Ann Karmanos Cancer Institute	32
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery NCT00828009	Phase 2	Completed	ECOG-ACRIN Cancer Research Group	70
Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer NCT00983268	Phase 1	Completed	Vanderbilt-Ingram Cancer Center	21
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors NCT00618813	N/A	Completed	Children's Oncology Group	35
SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial NCT07748611	Phase 2	Not yet recruiting	Northwestern University	125
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma NCT00003263	Phase 1	Completed	Fox Chase Cancer Center	6
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer NCT02888743	Phase 2	Active, not recruiting	National Cancer Institute (NCI)	110
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer NCT04406857	Phase 1	Terminated	National Cancer Institute (NCI)	1
Comparison of Acute Toxicities Between Patients Treated With Protons or Intensity Modulated Radiation Therapy After Surgery for the Treatment of Endometrial or Cervical Cancer NCT04567771	N/A	Recruiting	Mayo Clinic	120
Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma NCT02584829	Phase 1	Terminated	Fred Hutchinson Cancer Center	8
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer NCT06958328	Phase 3	Recruiting	NRG Oncology	356
CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL NCT04995536	Phase 1	Withdrawn	City of Hope Medical Center	—
Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction NCT00757172	Phase 2	Completed	Alliance for Clinical Trials in Oncology	70
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma NCT01878617	Phase 2	Active, not recruiting	St. Jude Children's Research Hospital	660
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer NCT03274687	Phase 3	Completed	NRG Oncology	296
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme NCT00085254	Phase 1	Completed	National Cancer Institute (NCI)	112
S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia NCT00005866	Phase 3	Completed	SWOG Cancer Research Network	240
sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC NCT04091867	Phase 1	Active, not recruiting	University of Colorado, Denver	3
T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia NCT00002718	Phase 2	Completed	Memorial Sloan Kettering Cancer Center	31
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma NCT00554788	Phase 3	Completed	Children's Oncology Group	60
Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases NCT00033254	Phase 3	Completed	National Cancer Institute (NCI)	332
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia NCT03914625	Phase 3	Active, not recruiting	National Cancer Institute (NCI)	6,720
Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma NCT03137888	Phase 2	Completed	Emory University	30
Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme NCT00238277	Phase 2	Terminated	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	15
TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas NCT03410901	Phase 1	Completed	Ronald Levy	14
A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers NCT03279237	Phase 1	Completed	Massachusetts General Hospital	25
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme NCT00027612	Phase 1	Completed	Alliance for Clinical Trials in Oncology	58
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery NCT01754519	Phase 2	Terminated	Roswell Park Cancer Institute	1
Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery NCT00373191	Observational	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	35
Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery NCT04391049	Phase 1	Active, not recruiting	NRG Oncology	16
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer NCT00114231	Phase 2	Completed	Alliance for Clinical Trials in Oncology	90
Combination Chemotherapy in Treating Patients With Lymphoma NCT00002835	Phase 3	Completed	M.D. Anderson Cancer Center	116
Radiation Therapy Following Surgery to Remove Brain Metastases NCT00003320	N/A	Completed	Jonsson Comprehensive Cancer Center	20
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery NCT00493025	Phase 2	Terminated	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	19
Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer NCT01264432	Phase 1	Completed	National Cancer Institute (NCI)	34
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer NCT00462501	N/A	Completed	Memorial Sloan Kettering Cancer Center	35
S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma NCT00070018	Phase 2	Completed	SWOG Cancer Research Network	46
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging NCT02773238	Phase 2	Completed	University of Washington	51
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT NCT00084838	Phase 2	Completed	Dana-Farber Cancer Institute	25
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer NCT05521997	Phase 2	Not yet recruiting	Washington University School of Medicine	42
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery NCT01486602	Phase 1	Completed	Alliance for Clinical Trials in Oncology	22
Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma NCT03338959	Phase 1	Recruiting	Fred Hutchinson Cancer Center	27
Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme NCT02337426	Phase 1	Completed	Virginia Commonwealth University	12
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer NCT01196390	Phase 3	Completed	National Cancer Institute (NCI)	203
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia NCT00022737	Phase 3	Completed	National Cancer Institute (NCI)	220
Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma NCT00357253	Phase 1	Completed	Pediatric Brain Tumor Consortium	24
S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer NCT00002772	Phase 3	Terminated	SWOG Cancer Research Network	602
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer NCT02402920	Phase 1	Completed	M.D. Anderson Cancer Center	83
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas NCT03576612	Phase 1	Completed	Candel Therapeutics, Inc.	41
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer NCT01711541	Phase 1	Completed	National Cancer Institute (NCI)	24
05-001: Treatment of Acute Lymphoblastic Leukemia in Children NCT00400946	Phase 3	Completed	Dana-Farber Cancer Institute	800
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor NCT00004068	Phase 2	Completed	St. Jude Children's Research Hospital	53
Bevacizumab and Radiation Therapy for Sarcomas NCT00356031	Phase 2	Completed	Massachusetts General Hospital	20
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia NCT00109837	Phase 2	Completed	SWOG Cancer Research Network	79
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer NCT03598257	Phase 2	Active, not recruiting	National Cancer Institute (NCI)	300
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant NCT00238368	Phase 2	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	59
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer NCT00109850	Phase 2	Terminated	SWOG Cancer Research Network	22
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer NCT00004859	Phase 3	Terminated	National Cancer Institute (NCI)	589
Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma NCT00079339	Phase 1	Completed	National Cancer Institute (NCI)	51
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer NCT00335816	Phase 2	Active, not recruiting	Memorial Sloan Kettering Cancer Center	248
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer NCT00003035	Phase 2	Completed	Georgetown University	40
Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer NCT02394535	Phase 1	Active, not recruiting	M.D. Anderson Cancer Center	25
BG & TMZ Therapy of Glioblastoma Multiforme NCT01269424	Phase 1	Completed	Stanton Gerson MD	10
Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy NCT02698254	N/A	Recruiting	M.D. Anderson Cancer Center	40
Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma NCT00088881	Phase 2	Terminated	National Cancer Institute (NCI)	62
Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy NCT00005988	Phase 1	Completed	Dana-Farber Cancer Institute	5
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma NCT00004024	Phase 2	Completed	Barbara Ann Karmanos Cancer Institute	60
Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors NCT00002472	Phase 2	Completed	Mayo Clinic	—
Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer NCT00003332	Phase 1	Completed	NYU Langone Health	36
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer NCT00316888	Phase 2	Completed	ECOG-ACRIN Cancer Research Group	63
Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer NCT00089024	Phase 2	Completed	University of Nebraska	29
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer NCT01958372	Phase 1	Completed	Barbara Ann Karmanos Cancer Institute	11
Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma NCT00049387	Phase 1	Completed	National Cancer Institute (NCI)	19
S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction NCT00086996	Phase 2	Completed	SWOG Cancer Research Network	98
S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00054054	Phase 2	Completed	SWOG Cancer Research Network	—
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer NCT00274937	Phase 3	Completed	Children's Oncology Group	111
Hyperpolarized Imaging in Diagnosing Participants With Glioma NCT03739411	Phase 1	Recruiting	Susan Chang	140
Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy NCT02203565	Phase 2	Completed	Stanford University	20
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer NCT00028730	Phase 2	Completed	Memorial Sloan Kettering Cancer Center	25
Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases NCT01767935	N/A	Terminated	Wake Forest University Health Sciences	1
Phase II Bevacizumab + Tax In Advanced Breast Cancer NCT00027885	Phase 2	Completed	Case Comprehensive Cancer Center	49
Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme NCT00006355	Phase 1	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	—
Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer NCT00021398	Phase 2	Completed	Fox Chase Cancer Center	23
Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases NCT00003324	N/A	Completed	Jonsson Comprehensive Cancer Center	61
Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma NCT03452930	Phase 1	Recruiting	M.D. Anderson Cancer Center	5
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer NCT00005840	Phase 1	Completed	Gynecologic Oncology Group	35
Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma NCT00544778	Phase 2	Terminated	City of Hope Medical Center	7
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme NCT00869401	Phase 1	Completed	Alliance for Clinical Trials in Oncology	217
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial NCT05050084	Phase 3	Active, not recruiting	NRG Oncology	2,050
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer NCT04751370	Phase 2	Active, not recruiting	National Cancer Institute (NCI)	31
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer NCT00003317	Phase 3	Completed	Alliance for Clinical Trials in Oncology	480
Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck NCT00003200	Phase 1	Completed	Dana-Farber Cancer Institute	22
Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia NCT00002844	Phase 2	Completed	M.D. Anderson Cancer Center	49
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas NCT00095771	Phase 1	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	36
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma NCT05535166	Phase 2	Recruiting	St. Jude Children's Research Hospital	130
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer NCT00354679	Phase 2	Completed	Memorial Sloan Kettering Cancer Center	34
Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma NCT04477200	Phase 1	Active, not recruiting	University of Michigan Rogel Cancer Center	68
IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma NCT03958383	Phase 1	Terminated	University of Wisconsin, Madison	8
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia NCT00002665	Phase 2	Completed	SWOG Cancer Research Network	50
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer NCT00686166	Phase 2	Completed	SWOG Cancer Research Network	83
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss NCT05382338	Phase 3	Recruiting	Children's Oncology Group	225
Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer NCT00080938	Phase 2	Completed	Eastern Cooperative Oncology Group	26
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer NCT00119262	Phase 2	Completed	National Cancer Institute (NCI)	226
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer NCT00084435	Phase 2	Withdrawn	SWOG Cancer Research Network	—
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET NCT00392327	Phase 3	Completed	Children's Oncology Group	379
Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides NCT03398161	Phase 2	Recruiting	M.D. Anderson Cancer Center	50
Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer NCT00026130	Phase 2	Completed	Alliance for Clinical Trials in Oncology	81
Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer NCT00068575	Phase 2	Completed	M.D. Anderson Cancer Center	29
Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma NCT00004109	Phase 1	Completed	M.D. Anderson Cancer Center	30
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer NCT05172245	Phase 1	Recruiting	National Cancer Institute (NCI)	46
Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer NCT03107780	Phase 1	Terminated	National Cancer Institute (NCI)	32
Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck NCT00096174	Phase 2	Completed	Eastern Cooperative Oncology Group	69
Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy NCT02615275	N/A	Active, not recruiting	M.D. Anderson Cancer Center	50
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer NCT00134004	Phase 2	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	210
S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery NCT00335959	Phase 2	Terminated	SWOG Cancer Research Network	7
Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer NCT00258323	Phase 2	Completed	Case Comprehensive Cancer Center	80
A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial NCT04216290	Phase 2	Active, not recruiting	National Cancer Institute (NCI)	95
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck NCT00720304	Phase 2	Completed	Case Comprehensive Cancer Center	43
Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery NCT03604991	Phase 2	Suspended	National Cancer Institute (NCI)	278
N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma NCT00253435	Phase 2	Completed	Children's Hospital Los Angeles	50
Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases NCT01417403	Phase 1	Terminated	Virginia Commonwealth University	10
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma NCT02112916	Phase 3	Active, not recruiting	National Cancer Institute (NCI)	847
Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer NCT00301808	Phase 2	Completed	Barbara Ann Karmanos Cancer Institute	29
FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma NCT02037048	Phase 2	Recruiting	Case Comprehensive Cancer Center	63
Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma NCT01849146	Phase 1	Completed	National Cancer Institute (NCI)	74
TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery NCT03297710	Phase 1	Completed	Mayo Clinic	7
Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma NCT04581382	Early Phase 1	Completed	Mayo Clinic	18
Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma NCT03174197	Phase 1	Active, not recruiting	M.D. Anderson Cancer Center	60
Combination Chemotherapy in Treating Patients With Sarcoma NCT00662233	Early Phase 1	Completed	Mayo Clinic	28
Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma NCT00265889	Phase 2	Completed	Case Comprehensive Cancer Center	42
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer NCT05245682	Early Phase 1	Active, not recruiting	Emory University	10
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma NCT07281417	Phase 2	Recruiting	National Cancer Institute (NCI)	108
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat NCT00017173	Phase 2	Terminated	SWOG Cancer Research Network	13
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer NCT00068692	Phase 3	Completed	National Cancer Institute (NCI)	225
Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery NCT00114179	Phase 2	Completed	National Cancer Institute (NCI)	82
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery NCT02180867	Phase 2	Completed	National Cancer Institute (NCI)	140
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer NCT01750073	Phase 2	Completed	University of Nebraska	92
Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients NCT02528942	N/A	Completed	University of Colorado, Denver	101
S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum NCT00070434	Phase 2	Withdrawn	SWOG Cancer Research Network	—
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma NCT00017147	Phase 3	Completed	SWOG Cancer Research Network	183
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery NCT00305877	Phase 2	Completed	National Cancer Institute (NCI)	137
Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer NCT05387915	Phase 2	Active, not recruiting	Emory University	33
Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer NCT00118053	Phase 2	Terminated	University of Medicine and Dentistry of New Jersey	5
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma NCT02567435	Phase 3	Active, not recruiting	National Cancer Institute (NCI)	325
A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma NCT04900792	Phase 1	Active, not recruiting	Bryan Allen	17
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma NCT04105374	Phase 2	Withdrawn	NRG Oncology	—
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC NCT02905591	Phase 2	Active, not recruiting	Joseph J. Cullen, MD, FACS	43
Fluciclovine (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study NCT04175431	Phase 2	Recruiting	University of Washington	100
Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer NCT00608205	Phase 3	Completed	Case Comprehensive Cancer Center	69
S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer NCT00003158	Phase 2	Completed	SWOG Cancer Research Network	96
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer NCT00238420	Phase 1	Completed	National Cancer Institute (NCI)	70
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma NCT00002461	Phase 2	Completed	Montefiore Medical Center	35
S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium NCT00055835	Phase 2	Completed	SWOG Cancer Research Network	7
Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer NCT04428671	Phase 1	Recruiting	Emory University	20
Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme NCT00052208	Phase 1	Completed	National Cancer Institute (NCI)	158
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function NCT02626312	Phase 1	Terminated	M.D. Anderson Cancer Center	36
SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma NCT00002548	Phase 3	Completed	SWOG Cancer Research Network	899
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer NCT00021320	Phase 2	Completed	Fox Chase Cancer Center	21
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations NCT02883049	Phase 3	Completed	National Cancer Institute (NCI)	5,949
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas NCT00042991	Phase 1	Completed	National Cancer Institute (NCI)	69
Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer NCT00022308	Phase 1	Completed	Fox Chase Cancer Center	—
Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer NCT02567422	Phase 1	Active, not recruiting	National Cancer Institute (NCI)	43
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas NCT01922076	Phase 1	Completed	National Cancer Institute (NCI)	46
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme NCT00770471	Phase 1	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	24
Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma NCT02420613	Phase 1	Completed	M.D. Anderson Cancer Center	18
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer NCT02912312	Phase 2	Recruiting	M.D. Anderson Cancer Center	805
Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma NCT00004123	Phase 1	Completed	M.D. Anderson Cancer Center	36
Multi-Atlas and Whole Body Radiomics Approaches for Image-Guided Treatment of Gynecologic Cancers NCT05358600	Phase 3	Recruiting	National Cancer Institute (NCI)	450
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer NCT03987386	Phase 3	Recruiting	M.D. Anderson Cancer Center	186
Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer NCT03524170	Phase 1	Recruiting	M.D. Anderson Cancer Center	24
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer NCT00255710	Phase 1	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	60
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer NCT00942357	Phase 3	Unknown status	Gynecologic Oncology Group	813
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma NCT00075582	Phase 3	Completed	Children's Oncology Group	390
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ NCT02352883	N/A	Active, not recruiting	ECOG-ACRIN Cancer Research Group	368
A Phase I/II Study of Intratumoral Injection of SD-101 NCT02254772	Phase 1	Completed	Robert Lowsky	9
Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer NCT01822496	Phase 2	Terminated	National Cancer Institute (NCI)	59
Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma NCT03528642	Phase 1	Active, not recruiting	National Cancer Institute (NCI)	40
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer NCT00005065	Phase 1	Completed	National Cancer Institute (NCI)	12
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT NCT04684368	Phase 2	Recruiting	Children's Oncology Group	160
Preoperative Radiosurgery for the Treatment of High Grade Glioma, The NeoGlioma Study NCT05030298	Phase 1	Not yet recruiting	Mayo Clinic	28
Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma NCT04047706	Phase 1	Active, not recruiting	Northwestern University	18
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas NCT00100802	Phase 2	Completed	Children's Oncology Group	118
Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma NCT04054167	Phase 2	Recruiting	M.D. Anderson Cancer Center	80
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery NCT06297265	N/A	Recruiting	University of Southern California	50